According to a new report published by Allied Market Research, titled, โMolecular Diagnostics Market: Global Opportunity Analysis and Industry Forecast, 2021-2030โ the global Molecular Diagnostics Market size was valued at $9.2 billion in 2020, and is projected to reach $23.9 billion by 2030, growing at a CAGR of 9.86% from 2021 to 2030. Molecular diagnostics is referred to as the discovery of genomic types, the purpose of which is to facilitate the detection, diagnosis, subclassification, prognosis, and monitoring of response to therapy. It is a collection of techniques used to analyze biological markers in the genome and proteomes and how their cells express their genes as proteins, applying molecular biology for medical testing.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ ๐๐จ๐ฎ๐๐ก๐๐ซ: https://www.alliedmarketresearch.com/request-sample/2170
COVID-19 Impact Analysis:
The COVID-19 pandemic has disrupted workflows in the healthcare sector globally. The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global molecular diagnostics market. The COVID-19 pandemic has stressed the healthcare systems globally and increased the need for the development of diagnostic instruments & diagnostic service centers. Increase in number of COVID-19 cases surged the demand for real time polymerase chain reaction (RT-PCR) test to detect COVID-19.
The growth of infectious diseases and various types of cancer has led to the growth of the molecular diagnosis market. In addition, increasing awareness and acceptance of personalized drugs and increasing biomarker recognition drive the growth of the market. However, stricter regulatory requirements for the approval of new nuclear diagnostic techniques are expected to hinder market growth over the forecast period. On the other hand, increasing adoption of nuclear diagnostics in emerging economies is expected to provide beneficial opportunities for market growth in the forecast period.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ: https://www.alliedmarketresearch.com/purchase-enquiry/2170
Asia-Pacific offers profitable in molecular diagnostics market opportunity for key players operating in the molecular diagnostics market, thereby registering the fastest growth rate during the forecast period, owing to the growing healthcare infrastructure, rise in disposable incomes, and well-established presence of domestic companies in the region. In addition, higher adoption and increase in use of molecular diagnostics, rapidly growing geriatric population, and rise in incidence of infectious diseases further fuel growth of the market in the region.
๐๐๐ฒ ๐๐๐ง๐๐๐ข๐ญ๐ฌ:
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the molecular diagnostics market analysis from 2020 to 2030 to identify the prevailing molecular diagnostics market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the molecular diagnostics market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global molecular diagnostics market trends, key players, market segments, application areas, and market growth strategies.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง: https://www.alliedmarketresearch.com/request-for-customization/2170
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
- Abbott Laboratories
- Agilent Technologies Inc.
- Becton Dickinson And Company
- Biomรฉrieux Sa
- Danaher Corporation
- F. Hoffmon La-Roche Ltd
- Grifols S.A
- Hologic Inc.
- Qiagen Inc
- Siemens Ag (Siemens Healthineers)
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Human Growth Hormone (hGH) Market
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com